Characteristics of Graves Disease in Haemodialysis Patients

Karima Boubaker, Hayet Kaaroud, Hedi Ben Maiz, Adel Kheder


Abnormal thyroid hormone production and metabolism are relatively common in chronic renal failure and in regular haemodialysis. Chronic kidney disease is associated with decreased thyroid hormone concentrations, especially triiodothyronine (T3), which are referred to as the euthyroid sick syndrome associated with increased severity of non-thyroidal illness and mortality in cats and dogs. Hyperthyroidism is a very unusual condition in patients undergoing regular haemodialysis. Graves disease is rare in these patients. To our knowledge, till now only 8 well documented cases of Graves disease have been reported in patients undergoing regular haemodialysis. The diagonsis of Graves disease must be evoked in presence or even in the absence of specific symptoms of the disease in haemodialysis patients. Diagnosis of hyperthyroidism may be difficult because of similar signs and symptoms as in uremia and manifestions are inhabitual. Indeed, hypertension, gynaecomastia, anaemia and hypercalemia can be seen in the two pathologies. Amost all patients undergoing regular haemodialysis received iodine 131 therapy for the treatment of Graves disease. This treatment is efficient and safe. Isolation of the patient is not recommanded. The risk for dialysis staff is to be contaminated by an accidental ingestion of a biologic fluid from the patient. The usual protection barriers used during the haemodialysis session are sufficient.

J Endocrinol Metab. 2012;2(6):212-215


Hyperthyroidism; Gravesís disease; Renal failure; Hemodialysis; 131 iodine; Radiation protection

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.